Creative Biolabs provides an advanced technical bridge for removing lipopolysaccharides (LPS) and bacterial toxins from complex aqueous solutions, ensuring compliance with the stringent <5 EU/kg/h regulatory threshold for parenterals. We utilize specialized dissociation strategies to resolve the "anchoring" effect, where endotoxins bind to target molecules, rendering them difficult to remove. Our high-recovery protocols effectively deplete high-molecular-weight aggregates while salvaging high-value proteins and small molecules. This integrated approach ensures superior purity, accurate analytical validation, and seamless preclinical progression for your biopharmaceutical products.
Creative Biolabs integrates multi-modal purification and 100,000 MWCO ultrafiltration to overcome low endotoxin recovery (LER) and "anchoring" effects. Our protocols utilize specialized sample conditioning to disrupt stable endotoxin-protein complexes, ensuring a log reduction value (LRV) > 4. Beyond LPS, we achieve a 20-fold reduction in bacterial protein toxins (e.g., SEA/SEC). By utilizing guanidinium-based hybrid adsorbers and synergistic affinity ligands, we maintain robust performance in high-conductivity environments (up to 43 mS/cm). This advanced framework reaches detection-limit purity (0.09 EU/10⁹ units), delivering clinical-grade safety for challenging biological lysates and phage-derived products.
Creative Biolabs provides a versatile portfolio of endotoxin removal solutions tailored to your molecule's unique characteristics. We specialize in precision membrane selection and buffer optimization to ensure that your high-value biologics achieve clinical-grade purity without compromising yield, stability, or biological activity during processing.
We utilize state-of-the-art PES and RC membranes with custom MWCO selection (10–300 kDa). Our diafiltration sequences maximize the clearance of pyrogenic impurities while stabilizing your product in optimized final formulations.
For challenging samples, we combine physical size-exclusion with chemical adsorption. Our adsorptive ultrafiltration and affinity-enhanced ligands scavenge residual LPS from complex biological lysates, including viral vectors and recombinant protein samples.
We overcome LER using non-denaturing dissociation chemistry. Parallel validation with LAL and EndoLISA ensures that masked endotoxins are liberated, removed, and analytically verified to satisfy regulatory standards.
We bridge the gap to the clinic with scalable high-throughput parallel cassette systems. All final purification and filling steps are conducted in certified environments to guarantee absolute product sterility.
Explore Our Tailored Purity Tiers — Inquire About Our Service Packages
Our workflow is designed as a collaborative journey, beginning with a deep understanding of your sample's unique chemical profile and concluding with the delivery of a clinical-grade, pyrogen-free product.
Creative Biolabs stands as a global authority in pyrogen management and biopharmaceutical purification. Our unique competitive edge lies in our hybrid adsorptive ultrafiltration technology. Unlike standard size-exclusion methods, our platform integrates charge-based adsorption to capture even the smallest endotoxin fragments. We leverage extensive "published data" to continuously optimize our membrane chemistry, ensuring superior log reduction values in high-salt or high-conductivity environments where traditional anion exchangers frequently fail. When you choose Creative Biolabs, you are investing in a process that prioritizes both product yield and absolute biological safety.
Experience the Creative Biolabs Advantage – Get a Detailed Quote Today
We employ a multi-step dissociation protocol. By adjusting the chemical environment of the buffer or introducing specific surfactants that are later removed, we break the affinity between the endotoxin and your product, making the endotoxin available for removal by the ultrafiltration membrane.
Creative Biolabs can accommodate a wide range of scales. We utilize low-dead-volume systems for samples as small as 10 mL and scalable parallel cassettes for larger pilot-scale batches, ensuring minimal loss regardless of volume.
Our process is conducted at controlled temperatures and optimized pressures to minimize shear stress. We prioritize maintaining the native conformation and biological activity of your molecules throughout the assay.
Creative Biolabs offers a comprehensive suite of purity and validation services to complement your endotoxin removal needs:
Creative Biolabs utilizes advanced membrane adsorption with ACPs-incorporated PVDF to achieve >99.8% endotoxin removal. We leverage high-capacity selective adsorption to ensure superior purification of protein solutions.
Learn More →Creative Biolabs provides specialized aqueous solubility analysis via HPLC-UV/VIS detection. We deliver precise physicochemical data to optimize ADME profiles, formulation strategies, and therapeutic efficacy for cancer immunotherapies.
Learn More →Creative Biolabs provides an industry-leading ultrafiltration assay, defined by high log reduction values, expert management of the low endotoxin recovery effect, and a commitment to clinical-grade purity. By leveraging our advanced platforms and cleanroom facilities, we ensure your biological products are safe, compliant, and ready for the most sensitive downstream applications.
For detailed project discussions or to receive a customized technical proposal, please reach out to our specialist team.